HIV Viral Suppression in TREAT Asia HIV Observational Database Enrolled Adults on Antiretroviral Therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia. Issue 8 (November 2016)
- Record Type:
- Journal Article
- Title:
- HIV Viral Suppression in TREAT Asia HIV Observational Database Enrolled Adults on Antiretroviral Therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia. Issue 8 (November 2016)
- Main Title:
- HIV Viral Suppression in TREAT Asia HIV Observational Database Enrolled Adults on Antiretroviral Therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia
- Authors:
- Boettiger, David C
Khol, Vohith
Durier, Nicolas
Law, Matthew
Sun, Ly Penh - Abstract:
- Background: The Social Health Clinic at the National Center for HIV/AIDS, Dermatology & STDs (SHC-NCHADS) in Phnom Penh is a major provider of antiretroviral therapy (ART) in Cambodia. However, patient access to viral load monitoring is uncommon. We conducted a cross-sectional evaluation of HIV viral load in SHC-NCHADS patients on ART to determine the proportion experiencing virological failure and to identify factors associated with virological failure in this population. Methods: Patients who had been using their current first-or second-line ART regimen for ≥6 months were eligible. Virological failure was defined as a viral load >1, 000 copies/ml, death, lost-to-follow-up or the absence of viral load testing despite presenting for care. Factors associated with virological failure were evaluated using logistic regression. Results: Overall, 463 patients (53.1% male, median age 42.1 years) were included in the investigation. At the time of current regimen initiation, median CD4 + T-cell count was 101 cells/mm 3 and 89.0% of patients had experienced a WHO stage III/IV event. At the time of testing/ last clinic visit, 28 (6.0%) patients met our definition of virological failure. Median viral load among those failing was 9, 633 copies/ml. Shorter time on current ART regimen, low CD4 + T-cell count at the time of viral load testing/last clinic visit and a record of suboptimal adherence were the strongest predictors of virological failure. Conclusions: This work demonstrates theBackground: The Social Health Clinic at the National Center for HIV/AIDS, Dermatology & STDs (SHC-NCHADS) in Phnom Penh is a major provider of antiretroviral therapy (ART) in Cambodia. However, patient access to viral load monitoring is uncommon. We conducted a cross-sectional evaluation of HIV viral load in SHC-NCHADS patients on ART to determine the proportion experiencing virological failure and to identify factors associated with virological failure in this population. Methods: Patients who had been using their current first-or second-line ART regimen for ≥6 months were eligible. Virological failure was defined as a viral load >1, 000 copies/ml, death, lost-to-follow-up or the absence of viral load testing despite presenting for care. Factors associated with virological failure were evaluated using logistic regression. Results: Overall, 463 patients (53.1% male, median age 42.1 years) were included in the investigation. At the time of current regimen initiation, median CD4 + T-cell count was 101 cells/mm 3 and 89.0% of patients had experienced a WHO stage III/IV event. At the time of testing/ last clinic visit, 28 (6.0%) patients met our definition of virological failure. Median viral load among those failing was 9, 633 copies/ml. Shorter time on current ART regimen, low CD4 + T-cell count at the time of viral load testing/last clinic visit and a record of suboptimal adherence were the strongest predictors of virological failure. Conclusions: This work demonstrates the high rate of viral suppression being achieved by the treatment programme at SHC-NCHADS and the need for future work to phase-in routine viral load monitoring in Cambodia. … (more)
- Is Part Of:
- Antiviral therapy. Volume 21:Issue 8(2016)
- Journal:
- Antiviral therapy
- Issue:
- Volume 21:Issue 8(2016)
- Issue Display:
- Volume 21, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 21
- Issue:
- 8
- Issue Sort Value:
- 2016-0021-0008-0000
- Page Start:
- 725
- Page End:
- 730
- Publication Date:
- 2016-11
- Subjects:
- Antiviral agents -- Periodicals
Antiviral Agents -- therapeutic use
Virus Diseases -- therapy
Viruses -- drug effects
Antiviral agents
Periodical
Electronic journals
Periodicals
616.9106 - Journal URLs:
- http://www.intmedpress.com/General/showSectionSub.cfm?SectionID=2&SectionSubID=1&SectionSubSubID=1 ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.3851/IMP3052 ↗
- Languages:
- English
- ISSNs:
- 1359-6535
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17222.xml